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In Brief
AMPA receptors are ionotropic glutamate
receptors co-expressed with auxiliary
proteins such as stargazin. Using LRET
and smFRET, Shaikh et al. show that
stargazin is positioned below the ligand-
binding domain of the receptor, acting as
a scaffold stabilizing a more compact,
open conformation of the AMPA receptor,
thus destabilizing the desensitized state.
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Fast excitatory synaptic signaling in the mammalian
brain is mediated by AMPA-type ionotropic gluta-
mate receptors. In neurons, AMPA receptors co-
assemble with auxiliary proteins, such as stargazin,
which can markedly alter receptor trafficking and
gating. Here, we used luminescence resonance en-
ergy transfer measurements to map distances be-
tween the full-length, functional AMPA receptor and
stargazin expressed in HEK293 cells and to deter-
mine the ensemble structural changes in the receptor
due to stargazin. In addition, we used single-mole-
cule fluorescence resonance energy transfer to study
the structural and conformational distribution of
the receptor and how this distribution is affected
by stargazin. Our nanopositioning data place star-
gazin below the AMPA receptor ligand-binding
domain, where it is well poised to act as a scaffold
to facilitate the long-range conformational selection
observations seen in single-molecule experiments.
These data support a model of stargazin acting to
stabilize or select conformational states that favor
activation.
INTRODUCTION
Glutamate receptors are the predominant mediators of excit-
atory synaptic signaling in the CNS, and they play an important
role in the regulation of synaptic strength, in learning and
memory, and in diverse neuropathologies, including epilepsy
and ischemia (Dingledine et al., 1999). Based on agonist affinity
profiles, glutamate receptors can be subdivided into three sub-
families: a-amino-5-methyl-3-hydroxy-4-isoxazole propionate
(AMPA) receptors, N-methyl-D-aspartate (NMDA) receptors,
and kainate receptors (Hollmann and Heinemann, 1994). Among
the three subtypes, AMPA receptors mediate the fast compo-
nent of excitatory signaling. As such, AMPA receptors and their328 Cell Reports 17, 328–335, October 4, 2016 ª 2016 The Author(s)
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synaptic transmission. With the discovery of the family of
related transmembrane AMPA receptor regulatory proteins
(TARPs), it has become increasingly clear that auxiliary proteins
modulate many aspects of AMPA receptor function, making a
vital contribution to excitatory synaptic- and neuronal-glial
signaling.
Stargazin, also known as g2, is the most well-characterized
member of the TARP family. Initially determined to play important
roles in AMPA receptor trafficking (Bats et al., 2007), stargazin
and the other TARPs more recently have been established as
key contributors to the diversity of signaling attributed to the
AMPA receptor, with this diversity arising from the additional
TARP-mediated modulation of channel gating (Cho et al., 2007;
Tomita et al., 2005). Electrophysiological measurements show
that stargazin increases the efficacy and potency of agonists
at AMPA receptors, slows glutamate-mediated AMPA receptor
deactivation and desensitization, accelerates recovery from
desensitization, reduces polyamine block, and enables a super-
activation of AMPA receptors (Carbone and Plested, 2016; Cho
et al., 2007; Maclean and Bowie, 2011; Tomita et al., 2005). The
modulation of AMPA receptor agonist efficacy has been attrib-
uted to stargazin increasing the closure of the ligand-binding
domain of the AMPA receptor (MacLean et al., 2014). However,
such a mechanism cannot account for all the effects of TARPs
on AMPA receptor gating, and indeed recent work has demon-
strated that TARPs also alter the various biophysical properties
of AMPA receptors through distinct processes (Dawe et al.,
2016). Therefore, a full explanation for how TARPs shape the
features of AMPA receptor gating is still largely unknown.
The structure of the AMPA receptor in isolation has been
studied extensively under various ligand conditions (D€urr et al.,
2014; Meyerson et al., 2014; Yelshanskaya et al., 2014). These
structures show that the receptor is a tetramer that is orga-
nized as a dimer of dimers, with extracellular amino-terminal
and ligand-binding domains, transmembrane segments, and
an intracellular C-terminal domain. Subunit crossover between
the amino-terminal and ligand-binding domains results in
different subunit groupings at each level, with the amino-terminal
domain comprising A/B and C/D dimers and the ligand-binding.
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Stargazin Modulation of AMPA Receptor Mutants Used
for LRET
(A) Representative whole-cell recordings show HEK cells expressing wild-type
GluA2, GluA2*-Y128C, GluA2*-D23C, and GluA2*-S27C in the presence of
stargazin (g2), and tandem GluA2*-D23C/g2, in response to 10 mM glutamate
(Glu) alone (upper panel) and either 10 mM glutamate or 2 mM kainate (KA) in
the presence of 100 mM cyclothiazide (CTZ) (lower panel).
(B) Summary data show the kainate-to-glutamate response ratio. Error bars
are SEM.domain comprising A/D and B/C dimers. These structures also
show that the ligand-binding domain undergoes a cleft closure
upon binding agonists, and this cleft closure conformational
change is thought to drive receptor activation (channel open-
ing). In the continued presence of agonists, the dimer interface
at the ligand-binding domain decouples, leading to receptor
desensitization (Gonzalez et al., 2010). This decoupling within
ligand-binding domain dimers is also observed between the
amino-terminal domain dimers. The extent of this decoupling is
still unclear, as a wide range of decoupling between the dimers
has been observed in the reported X-ray and cryoelectronmicro-
scopy (cryo-EM) structures (D€urr et al., 2014; Meyerson et al.,
2014; Yelshanskaya et al., 2014).
Here we advance a model of the AMPA receptor-stargazin
complex by positioning a claudin-based homology model ofstargazin through luminescence resonance energy transfer
(LRET)-derived distance measurements between the AMPA
receptor and the stargazin. This model of the complex in
HEK293 cells is comparable to the recently published cryo-EM
structures of the AMPA receptor in complex with stargazin,
also expressed in HEK cells (Twomey et al., 2016; Zhao et al.,
2016). Furthermore, we have used LRET and single-molecule
fluorescence resonance energy transfer (smFRET) to examine
the extent of amino-terminal domain decoupling associated
with desensitization, and thus we show that the receptor favors
less decoupling in the presence of stargazin. This result suggests
that stargazin acts as a scaffold to reduce decoupling between
subunits and, hence, stabilizes the active open conformation of
the receptor.
RESULTS AND DISCUSSION
Mapping Stargazin to the AMPA Receptor
To perform the LRET investigations to measure the distance
between the AMPA receptor and stargazin, we modified the
GluA2 subunit by mutating the surface-accessible cysteine res-
idues at positions 89, 196, and 436 to serines. Additionally, we
introduced a Factor Xa protease recognition sequence at posi-
tion 228, allowing us to perform the experiments under near
physiological conditions with proteins expressed in HEK293T
cells without the need for purification. This site was chosen as
it required minimal substitution from residues TDGD to IDGR.
By performing LRET measurements before and after protease
cleavage, we were able to quantify the background and deter-
mine the specific signal arising from GluA2 receptors (Dolino
et al., 2014; Gonzalez et al., 2008; MacLean et al., 2014; Ramb-
hadran et al., 2010, 2011; Sirrieh et al., 2013, 2015). This basal
LRET construct hereafter is referred to as GluA2*. For our map-
ping studies, the tyrosine at site 128 was further mutated to
cysteine, introducing a reactive site for a maleimide derivative
of terbium chelate, which served as the donor fluorophore.
We confirmed that this construct, GluA2*Y128C, was func-
tional and that stargazin modulation was intact by measuring
kainate-to-glutamate ratios electrophysiologically (Figure 1).
Kainate is a poor agonist at AMPA receptors, but in the presence
of stargazin it becomes more efficacious (Tomita et al., 2005).
We found that, when stargazin was co-transfected, kainate
was equally efficacious for both wild-type GluA2 as well as
GluA2*Y128C (kainate-to-glutamate ratio of 0.76 ± 0.03, n = 4
for wild-type; 0.76 ± 0.02, n = 5 for GluA2*Y128C; p = 0.63). To
measure the distances between the GluA2 subunit and starga-
zin, acceptor fluorophores were tagged on stargazin by intro-
ducing the unnatural amino acid p-acetyl-L-phenylalanine at
various sites on the extracellular domain of stargazin. The keto
group of p-acetyl-L-phenylalanine could then be coupled to
hydrazide derivatives of either fluorescein or Alexa 555. The
background-subtracted LRET lifetime decays of GluA2*Y128C
and stargazin tagged with donor and acceptor fluorophores,
respectively, are shown in Figure 2A. The donor-only lifetimes
for the GluA2*Y128C receptor tagged with terbium chelate in
the absence of acceptor labeling is shown in Figure S1. Based
on the donor-only and sensitized acceptor lifetimes, the dis-
tances between site 128 on GluA2 and sites 44, 51, and 61 onCell Reports 17, 328–335, October 4, 2016 329
Figure 2. LRET-Nanopositioning System-Based Model of AMPA Receptor-Stargazin Interaction
(A) LRET lifetimes between GluA2 amino-terminal domain site 128 of the apo AMPA receptor and sites 44 (green), 51 (magenta), and 61 (blue) in the extracellular
region of stargazin (g2) are shown. See also Figure S1.
(B) Stargazin homology model (orange) with the root mean positions of its fluorophores shown as red, green, and blue hard spheres. The LRET-determined
distances to the donor fluorophore (39.9 A˚ for g2 site 44, 34.5 A˚ for g2 site 51, and 49.9 A˚ for g2 site 61) were used to generate the larger spheres. The AMPA
receptor structure and stargazin model were positioned to place the terbium fluorophore at the point of intersection of the LRET radii spheres.
(C) Our model of the means of interaction between the AMPA receptor and stargazin. See also Figure S2.stargazin were determined using the Fo¨rster equation (Table S1).
The errors reported in the table are determined from error
propagation from the error in the exponential fits of the data.
The error in the absolute distances due to k2 is 10%. The use
of an isotropic atomic donor reduces this error even further, as
does the long lifetime of terbium luminescence, which allows
for sufficient rotational diffusion of the acceptor (dos Remedios
and Moens, 1995).
LRET lifetimes also were obtained between the AMPA recep-
tor and stargazin in the presence of glutamate (Figure S1). The
distances between site 128 on AMPA receptor and sites 44
and 51 on stargazin in the presence of glutamate were 39.0
and 37.5 A˚. These distances were slightly different from the
39.9 and 34.5 A˚, respectively, under apo conditions (Table S1),
and they could indicate local rearrangements between the
AMPA receptor and stargazin upon binding glutamate. The
LRET data obtainedwith intact HEK293 cells did not show disso-
ciation of stargazin from the AMPA receptor in the presence
of glutamate, as previously reported (Morimoto-Tomita et al.,
2009). However, local rearrangements could account for the
autoinactivation of AMPA receptors at high glutamate concen-
trations in the presence of stargazin, and they might underlie
the observed dissociation of stargazin from the AMPA receptors
under western blot conditions where membrane preparations
were used (Morimoto-Tomita et al., 2009).
Based on the distances obtained from LRET measurements,
we used a method similar to the nanopositioning methods
previously reported (Kalinin et al., 2012; Muschielok andMichae-
lis, 2011; Tatulian, 2014). The SWISS-MODEL server (Biasini
et al., 2014) was used, which generated a homology model for
stargazin based on claudin-19. Then the approximate root
mean positions of the respective fluorophores were calculated
as previously described (Kalinin et al., 2012) for both the AMPA
receptor structure and our generated stargazin model. Spheres330 Cell Reports 17, 328–335, October 4, 2016were drawn around the positions of the acceptor fluorophore us-
ing the LRET-determined distances as radii (Figure 2B). The sites
of intersection of the three spheres were then considered as the
likely spatial position of the donor fluorophore on the AMPA re-
ceptor. A series of rigid-body translations and rotations were
performed to superpose the calculated root mean position of
the donor fluorophore with the triangulated points of intersec-
tion of the acceptor fluorophore spheres, with the additional
constraint of maintaining the transmembrane domains of both
the AMPA receptor and stargazin parallel such that they both
were positioned in themembrane. Themodel that best fit the dis-
tance, with minimal steric clashes (Figure 2C), positioned the
extracellular domain of stargazin next to the ligand-binding
domain of the AMPA receptor, with a significant portion interact-
ing with the linker regions and placed below the lower lobe of the
ligand-binding domain. While the precise location of stargazin
was harder to predict based on the LRET distances, placing star-
gazin close to the B or D ligand-binding domain in the A-B and
C-D interfaces provided the most interactions between the
transmembrane segments of stargazin and the AMPA receptor.
Additional poses also were obtained (Figure S2); however, these
showed minimal interactions at the level of the transmembrane
segments of the AMPA receptor and stargazin.
Our model of stargazin in complex with the AMPA receptor
was able to account for the previous functional and LRET mea-
surements, which showed the ligand-binding domain of the
AMPA receptor being more closed in the presence of stargazin
(MacLean et al., 2014). It also was consistent with the prior
peptide-based mapping of stargazin on the AMPA receptor
that showed significant interactions between the extracellular
domain of stargazin and the ligand-binding domain of the
AMPA receptor (Cais et al., 2014).
While this paper was under review, two laboratories published
cryo-EM structures of the AMPA receptor-stargazin complex
(Twomey et al., 2016; Zhao et al., 2016). Both structures showed
that stargazin interacts with the B and D subunits. One of the
structures showed weak interactions of stargazin with the A
and C subunits (Zhao et al., 2016). These data are remarkably
consistent with our predicted model. The similarity of our model,
generated based on LRET experiments on AMPA receptors
co-expressed with stargazin in HEK293 cells, to the cryo-EM
structures of purified protein, with one structure being of a tan-
dem construct between the AMPA receptor and stargazin,
speaks to the robustness of the structure of the complex.
Decoupling of Amino-Terminal Domain Dimers of the
AMPA Receptor due to Desensitization
Recent structures of the AMPA receptor show decoupling be-
tween the amino-terminal domains of the AMPA receptor asso-
ciated with desensitization (D€urr et al., 2014; Meyerson et al.,
2014; Yelshanskaya et al., 2014). The extent of decoupling at
the amino-terminal domain has been debated, with some struc-
tures showing large decoupling and others smaller or no decou-
pling (D€urr et al., 2014; Meyerson et al., 2014; Yelshanskaya
et al., 2014). Decoupling, as referred to here, is decoupling
between the dimers at the amino-terminal domain and not de-
coupling within the dimer as seen in the ligand-binding domain
(Gonzalez et al., 2010). Here we used LRET to study the inter-
subunit distance between proximal subunits B and D at sites
23 and 27. For these measurements, cysteines were introduced
at site 23 or 27 in the GluA2* background. In both GluA2*D23C
and GluA2*S27C, stargazin modulation of kainate efficacy was
intact (Figure 1; kainate-to-glutamate ratio of 0.71 ± 0.03, n = 4
for GluA2*D23C, p = 0.34 compared to wild-type; 0.72 ± 0.03,
n = 4 for GluA2* S27C, p = 0.42 compared to wild-type).
The receptors were tagged with a 1:4 ratio of acceptor:donor,
thus ensuring that the majority of the receptors probed had at
most one acceptor fluorophore per receptor (Cha et al., 1999).
Labeling the same site on the four subunits allows measurement
of the inter-subunit distance at the same structural point on the
four subunits. Measurements of the desensitized conformations
were obtained using saturating glutamate (1 mM), and measure-
ments of the open conformation were obtained using satu-
rating glutamate as well as cyclothiazide (100 mM). The receptors
tagged with donor alone showed no significant changes be-
tween these conditions, and they could be well represented by
a single exponential decay for both sites 23 and 27 (Figure S3).
The background-subtracted LRET lifetimes for the donor-
acceptor tagged receptors also could be represented by a single
exponential decay (Figure 3), consistent with the structure of the
AMPA receptor that shows the shortest distance for site 23 and
site 27 is the inter-subunit distance between subunits B and D.
The distances across the other subunits were significantly longer
than the R0 = 45 A˚ of the terbium-fluorescein LRET pair, and,
consistent with this, they did not significantly contribute to the
LRET signal. Based on the donor-only and donor-acceptor life-
times, the distances were calculated using the Fo¨rster equation
(Table S2).
These ensemble measurements show that the average resting
conformation and the average open (glutamate-and-cyclothia-
zide-bound) conformation both exhibit shorter distances relative
to the predominantly desensitized (glutamate-bound) conforma-tion of the receptor. The change in distance between the open
state and the desensitized conformation showed increases of
3.3 ± 0.1 A˚ and 4.3 ± 0.04 A˚ at sites 23 and 27, respectively.
This increase indicated a decoupling between the subunits at
the amino-terminal domain upon desensitization. Since a wide
range of decoupling has been noted in the X-ray (PDB: 4U4F)
(D€urr et al., 2014; Yelshanskaya et al., 2014) and cryo-EM struc-
tures (EMD2686, EMD2687, and EMD2688) (Meyerson et al.,
2014), we studied this decoupling further using smFRET studies.
The smFRET histogram for the glutamate-bound, desensitized
AMPA receptor labeled at site 23 (GluA2*D23C) is shown in Fig-
ure 4A. The data were analyzed using Hidden Markov Modeling
software (HaMMy) (McKinney et al., 2006) to obtain the states
that the protein samples (representative traces shown in Fig-
ure 4B). The combined histograms for all the molecules could
be fit to the same states observed in the HaMMy analysis. More-
over, analyzing the raw data with wavelet denoising (Dolino et al.,
2015; Landes et al., 2011;Ramaswamyet al., 2012) resulted in the
same states (Figure S4), providing independent confirmation of
the existence of these states. The analysis of the smFRET data
showed that under desensitized conditions the protein samples
varying degrees of decoupling, with stabilization into predomi-
nantly four conformational states. Two additional states also
were present that, combined, comprised less than 1%of thepop-
ulationandwere likely due to backgroundor to denaturedprotein.
The occupancy, FRET efficiency, and corresponding FRET dis-
tances of the four significant states are shown in Table S3.
These data reveal the complete spectrum of states that
the amino-terminal domain subunits probe under desensitized
conditions. It is interesting to note that the FRET distances
correlated well with previously published X-ray and cryo-EM
structures (Table S3) (Meyerson et al., 2014; Yelshanskaya
et al., 2014), suggesting that the desensitized receptor sam-
ples each of these structures to varying degrees. We also have
studied the receptor under predominantly open conditions, i.e.,
with both glutamate and cyclothiazide bound, using smFRET
(Figure 4C). Consistent with the LRET data, the smFRET data
showed that, when bound to both cyclothiazide and glutamate,
the receptor occupied predominantly high-efficiency FRET
states. The data could be fit to three conformational states,
with 98% of the receptor being in the conformations having
distances of 36 and 41 A˚. This suggests a compact receptor
with very little decoupling at the amino-terminal domain under
open-channel conditions.
The sampling of multiple conformations of the AMPA receptor
as seen with our smFRET data was also consistent with electro-
physiological evidence for multiple kinetic states for a single
AMPA receptor functional condition (Jin et al., 2003). At least
two distinct desensitized states have been identified based on
kinetic analysis of the GluA1 and GluA4 subtypes of AMPA
receptors (Robert and Howe, 2003), and other iGluRs also popu-
late multiple desensitized states (Amico-Ruvio and Popescu,
2010; Borschel et al., 2012; Kussius et al., 2009).
Decoupling of Amino-Terminal Domains of the AMPA
Receptor in the Presence of Stargazin
LRET measurements also were performed on AMPA receptors
co-transfected with stargazin. Comparing the LRET lifetimes atCell Reports 17, 328–335, October 4, 2016 331
Figure 3. Amino-Terminal Domain Subunits of the AMPA Receptor Decouple upon Desensitization and Are Stabilized in the Presence of
Stargazin
LRET lifetimes between the proximal GluA2 subunits at site 23 (top) and at site 27 (bottom). Insets show location of sites 23 and 27 on the AMPA receptor.
(A and E) Apo or resting condition is shown.
(B and F) Desensitized condition in the presence of 1 mM glutamate is shown.
(C and G) Open condition in the presence of 1 mM glutamate + 100 mM CTZ is shown.
(D) GluA2 L483Y non-desensitizing mutant (open conformation) in the presence of 1 mM glutamate. See also Figure S3.sites 23 and 27 for the AMPA receptor in the absence and pres-
ence of stargazin (Figure 3; Table S2), it was evident that the
average distanceswere not altered under open conditions. How-
ever, the distances were shorter under resting and desensitized
conditions when stargazin was present, with the effect being
most dramatic under the desensitized state. Given that the
desensitized receptor was the most decoupled, these results
suggest that the presence of stargazin reduces the extent of
decoupling, implying a mechanism to explain the increased
recovery from desensitization.
To see the shift in the occupancy of the different states, we
obtained smFRET histograms of the AMPA receptor/stargazin
tandem construct tagged at site 23 (GluA2*-D23C/g2) in the
desensitized (glutamate-bound) condition, and we compared
it to our previous data of the AMPA receptor without stargazin.
Stargazin modulation of kainate efficacy was intact for the
tandem GluA2*D23C/g2 construct (Figure 1; kainate-to-gluta-
mate ratio of 0.75 ± 0.02, n = 4, p = 0.81 compared to wild-
type). The smFRET histograms as well as the individual traces332 Cell Reports 17, 328–335, October 4, 2016showed that similar numbers of states were observed in
the desensitized receptor in the presence of stargazin as in
its absence (Figure 4D). However, in the presence of stargazin,
each of the states observed in the receptor in the absence
of stargazin was shifted to higher efficiencies (less decou-
pling). Thus, although the overall landscape of the receptor
in the absence and presence of stargazin is similar, the
shorter distance seen in each state suggests a more compact
(less decoupled) receptor (Table S3) under desensitized
conditions.
The overall reduction in decoupling caused by stargazin in
each conformational state is consistent between both our
LRET and smFRET data, suggesting that stargazin acts as a
scaffold, stabilizing a more compact structure of the AMPA
receptor. Such stabilization by stargazin of the AMPA receptor
would account for the stabilization of the receptor in an open,
activated conformation and destabilization of the desensi-
tized conformations, perhaps contributing to the accelerated
recovery from desensitization, increased agonist efficacy and
Figure 4. The Presence of Stargazin Pro-
motes a More Compact Form of the AMPA
Receptor
(A–D) The smFRET histograms show the pop-
ulation distribution of the AMPA receptor labeled
at site 23 of the amino-terminal domain under
(A) desensitized condition (presence of 1 mM
glutamate), with corresponding representative
smFRET traces shown in (B), (C) open condition
(presence of 1 mM glutamate + 100 mMCTZ), and
(D) in tandemwith g2 in the desensitized condition
(presence of 1 mM glutamate). Each state in (A) is
accompanied by a cartoon representation of the
corresponding distance between sites 23 of the
B and D subunits of the AMPA receptor. State 1,
yellow peak; state 2, magenta peak; state 3, cyan
peak; state 4, blue peak.potency, and resensitization of the AMPA receptor by starga-
zin. Thus, our work provides insight into the structural basis
for the functional consequences of stargazin on the AMPA
receptor.
EXPERIMENTAL PROCEDURES
Cloning and Mutagenesis
To specifically label cysteines on GluA2 using maleimide fluorophore deriv-
atives, the extracellular, surface-exposed, non-disulfide-bonded cysteines
at positions 89, 196, and 436 (numbered according to the GluA2 crystal
structure PDB: 3KG2) were mutated to serines. Additionally, a Factor Xa
protease site (IDGR) was introduced at position 228 with the mutations
T228I and D231R. Upon cleavage, the labeled amino-terminal domains
dissociate, thus removing the specific AMPA receptor contribution to the
LRET signal and enabling distance measurements in full-length receptors
expressed in whole cells, without the need for protein solubilization and
purification. This background construct, called GluA2*, was further modi-
fied to substitute cysteines at specific sites of the amino-terminal domain
for fluorophore labeling; the mutants generated were GluA2*-D23C,
GluA2*-S27C, and GluA2*-Y128C. For measuring AMPA receptor-stargazin
(STG) distances, Amber TAG stop codons were introduced at positions
44, 51, and 61 of g2, and the original stop codon was mutated to TAA. A
GluA2*-D23C/stargazin tandem construct was generated by replacing the
stop codon with a stretch of GGSGGSGGSG residues followed by the star-
gazin sequence at the C terminus (called GluA2*-D23C/g2). All mutations
were introduced using standard site-directed mutagenesis protocols and
checked by sequencing.
Functional Characterization of Mutants
HEK293 tsA201 cells at 40%–50% confluency were transfected using jet-
Prime (PolyPlus) following the manufacturer’s instructions with the relevant
GluA2, g2, and eGFP DNA at a mass ratio of 10:15:1 mg/10 ml media. After
10–12 hr of incubation, cells were re-plated at a low density. NBQX (2,3-Di-
oxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide) (10 mM)
was present in the medium during and after transfection. Whole-cell
patch-clamp recordings were performed 24–48 hr after transfection using
fire-polished borosilicate glass pipettes with 3–5 MU resistance, filled
with the following internal solution: 135 mM CsF, 33 mM CsOH, 2 mMCellMgCl2, 1 mM CaCl2, 11 mM EGTA, and 10 mM
HEPES (pH 7.4). The external solution was
as follows: 150 mM NaCl, 1 mM CaCl2, and
10 mM HEPES (pH 7.4). Solutions with no added
ligand, 10 mM glutamate, 2 mM kainate, and/or
100 mM cyclothiazide, were locally applied tolifted cells using a stepper motor system (SF-77B, Warner Instruments)
with triple-barrel tubing. Recordings were performed using an Axopatch
200B amplifier (Molecular Devices) at 60 mV hold potential, acquired at
10 kHz using pCLAMP10 software (Molecular Devices) and filtered online
at 5 kHz.
LRET Investigations
HEK293T cells were transiently transfected with the constructs described
above, using jetPrime PolyPlus according to the manufacturer’s guidelines,
and they were maintained in 30 mM NBQX during and after transfection. For
LRET measurements, cells were transfected with either GluA2 DNA alone or
a GluA2:g2 microgram ratio of 5:15.
To incorporate the unnatural amino acid p-acetyl-L-phenylalanine into the g2
protein during translation, cells were co-transfected with plasmids containing
suppressor tRNACUA and the p-acetyl-L-phenylalanyl-tRNA synthetase, along
with the GluA2 and g2 plasmids. After transfection, the medium was supple-
mented with 500 mM amino acid p-acetyl-L-phenylalanine (AcF) (RSP Amino
Acids).
LRET experiments were done 48 hr post-transfection. Cells were collected
and washed three to four times using extracellular buffer containing 145 mM
NaCl, 1.8 mM MgCl2, 1 mM CaCl2, 3 mM KCl, 10 mM glucose, and 10 mM
HEPES (pH 7.4). The washed HEK cells were then labeled with 300 nM donor
and 75 nM acceptor fluorophores in 3 ml extracellular buffer, rotating in the
dark for 1 hr. The donor fluorophore was always terbium chelate (Invitrogen),
while acceptor fluorophores were either Alexa 555 hydrazide or fluorescein
thiosemicarbazide (Thermo Fisher Scientific) for cells expressing AcF-incorpo-
rated g2 and fluorescein maleimide (Thermo Fisher Scientific) for cysteine
mutants. After labeling, cells were washed and resuspended in 2 ml buffer
and used for LRET measurements.
A cuvette-based LRET system, QuantaMaster model QM3-SS with Fluores-
can Software (Photon Technology International), was used for analysis.
All samples were excited at 337 nm. Emission was detected at 545 nm
for donor-only samples, at 515 nm for fluorescein-labeled samples, and
at 565 nm for Alexa 555-labeled samples. To study the effect of g2 on
the AMPA receptor amino-terminal domains, distance measurements were
collected in the presence of 1 mM glutamate alone as well as with 100 mM
cyclothiazide (CTZ). LRET measurements were taken before and after pro-
tease cleavage by Factor Xa to enable quantification and subtraction of
background fluorescence in order to isolate the specific signal due the
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fluorophores were calculated from LRET lifetime (tDA) and donor-only lifetime
(tD) using the Fo¨rster equation:
R=R0

tDA
tD  tDA
1=6
(Equation 1)
where R is the distance between donor and acceptor fluorophore, R0 is
the distance yielding half-maximal energy transfer for a given fluorophore
pair (65 A˚ for terbium-Alexa 555 and 45 A˚ for terbium-fluorescein), tD is
the measured lifetime of the donor when bound to the protein and without
acceptor fluorophore present, and tDA is the lifetime of the donor fluorophore
when bound to the protein and transferring energy to the acceptor fluoro-
phore, which we have measured here as the lifetime of the sensitized emis-
sion of the acceptor.
Nanopositioning
A homology model of stargazin was constructed using the SWISS-MODEL
server (Biasini et al., 2014), which generated a model based on claudin-19.
Root mean positions of the fluorophores were calculated using the FRET
positioning and screening software as previously described (Kalinin et al.,
2012). Based on the root mean positions of the acceptor fluorophores on
the stargazin model, spheres were drawn in PyMOL centered upon those po-
sitions, with radii corresponding to the distances derived from the LRET
measurements. The sites of intersection of the three spheres were then
considered to be the triangulated position where we would expect to locate
the root mean position of the donor fluorophore. The structure of the AMPA
receptor (PDB: 3KG2) with the calculated accessible volume and root mean
position of Tyr128Cys-Tb chelate underwent a series of rigid-body transla-
tions and rotations, and we visually inspected until a model was found that
superposed the triangulated point of intersection with the calculated root
mean position of terbium. Additional constraints of maintaining the trans-
membrane domains in a logical position and minimizing steric clashing
were used to generate the models shown.
smFRET Measurements
HEK293T cells were transfected, harvested, and washed as described for the
LRET investigations. The cells were then labeled with maleimide derivatives of
300 nM Alexa 555 donor and 1.2 mM Alexa 647 (Invitrogen) acceptor fluoro-
phores. After washing, the cells were solubilized in PBS containing 1mMn-do-
decyl-b-D-maltoside (DDM) and 0.2 mM cholesteryl hemisuccinate (CHS) with
protease inhibitor (Thermo Fisher Scientific). The lysed cells were centrifuged
at 100,0003 g at 4C for 1 hr and the supernatant was used for smFRET sam-
ple preparation. Slides for smFRET studies were prepared and measurements
were taken as described previously (Dolino et al., 2015). The background-cor-
rected signal was used to calculate the FRET efficiency using the following
equation:
EA =
IA
IA + ID
(Equation 2)
where EA is the apparent FRET efficiency, IA is the background-corrected
acceptor fluorescence intensity, and ID is the background-corrected donor
fluorescence intensity. From this FRET efficiency, the distance was deter-
mined through the Fo¨rster equation,
E =
 
1+
"
R
R0
6#!1
(Equation 3)
where R is the distance between the dyes, and R0 is the Fo¨rster radius. The
Fo¨rster radius is 51 A˚ for the Alexa Fluor 555-Alexa Fluor 647 fluorophore
pair used for these experiments. Error in FRET efficiencies was set to 0.03,
based on measurements under the same conditions performed with a
rigid DNA double strand. After processing the data, the traces were further
filtered for single-molecule verification and excluded if they showed multi-
step bleaching or exceptionally high background adapted from a normal
distribution.334 Cell Reports 17, 328–335, October 4, 2016Statistics
For electrophysiological analysis of the mutants, n represents a single cell. The
representative traces are an average of five to ten individual traces from a
single cell. The statistical significance was calculated using Student’s t test
with p < 0.05 considered significant. For LRET measurements, each sample
was scanned three times, each scan was an average of 99 sweeps, and
each sweep comprised 500 pulses. The LRET lifetimes were normalized for
comparison, and error was calculated using the Error Propagation Calculator
developed by ThomasHuber in the Physics Department of Gustavus Adolphus
College. The smFRET data were obtained from 12 molecules (10,282 data
points) under open receptor conditions, 16 molecules (2,384 data points)
under desensitized receptor conditions without stargazin, and 28 molecules
(4,269 data points) under desensitized receptor conditions with stargazin. All
data were analyzed using Origin 9.0 (OriginLab) and MATLAB (R2015b; The
Mathworks, Natick, MA)
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